nasdaqqdel
Quidel Corporation (NASDAQ:QDEL) is a diagnostic testing company. Although it covers other important areas such as flu, respiratory, viral and herpes testing, it was “put on the map” by COVID-19 tests after 2019. Earnings jumped more than tenfold in 2020 to $18.60 a share, up from $1.73 a share in 2019.* They “declined” slightly to $16.49 in 2021. The company has already booked $11.31 a share in the first quarter, and we regard our 2022 earnings estimate of $17.50 a share, “splitting” the difference between the two previous years, as conservative. Q1 2022 hedge fund letters, conferences and mo...
ValueWalk
Another astonishing quarter as bond prices dropped sharply and bond yields advanced. This is clearly in anticipation of a strong growth recovery. Q1 2021 hedge fund letters, conferences and more Stock vs BondsThe long-term bond price index fell 10% last quarter and the major stock index was up 11% adding 21% to the return of stocks vs bonds and lifting stock prices and valuation to a new all-time high. As indicated in our latest quarterly update where we referred to bonds as "toxic" for long term investors as age-based allocation methods leave older investors with a dangerous overexposure to b...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら